Federal Circuit Confirms That Isolated DNA May Be Patented
Assoc. for Molecular Pathology v. Myriad Genetics, No. 2010-1426 (Fed. Cir. 2011)[More...]
View ArticleFederal Circuit Affirms Validity Of Argatroban Patent
Mitsubishi Chemical Corp. v. Barr Labs., No. 2010-1432 (Fed. Cir. 2011)[More...]
View ArticleFederal Trade Commission Issues Final Report On Authorized Generic Drugs
The Federal Trade Commission announced earlier today that it has completed its study into the competitive effects of authorized generic drugs. The FTC's final report, entitled "Authorized Generic...
View ArticleFederal Circuit Confines 271(E)(1) Safe Harbor To Pre-Approval Activities
Classen Immunotherapies v. Biogen IDEC et al., Nos. 2006-1634, -1649 (Fed. Cir. 2011)[More...]
View ArticleACI "Advanced Forum On Biotech Patents" Conference, Boston, Nov. 30 - Dec. 1
American Conference Institute will be holding its 13th Advanced Forum on Biotech Patents conference at the Omni Parker House hotel in Boston, MA, November 30th to December 1st. ACI subtitles this...
View ArticleDistrict Of Delaware Rules That API Manufacturer Cannot Be Sued Under Section...
by John L. Abramic[More...]
View ArticleFederal Circuit Affirms Invalidity Of Teva's Patent On Rosuvastatin Formulation
Teva Pharm. Indus. Ltd. v. AstraZeneca Pharms. LP, No. 2011-1091 (Fed. Cir.)[More...]
View ArticleFederal Circuit Vacates Preliminary Injunction Entered Against Mylan In...
Warner Chilcott Labs. v. Mylan Pharms. Inc., No. 2011-1611 (Fed. Cir.)[More...]
View ArticleCephalon Ordered To Pay Anchen's Attorney Fees For Maintaining Suit Despite...
In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, No. 09-MD-2118-SLR (D. Del.)[More...]
View ArticleFederal Circuit: Section Viii Statement Avoids Infringement Under § 271(E)(2)
AstraZeneca Pharms. v. Apotex et al., No. 11-1182 (Fed. Cir.)[More...]
View ArticleDistrict Of Delaware: Paragraph IV Certification Not Required For...
Cephalon v. Sandoz, No. 11-821-SLR (D. Del.)[More...]
View ArticleThird Circuit Issues Landmark Decision In Reverse Payment Case, Setting Up...
In Re: K-Dur Antitrust Litigation, No. 10-2077 (3d Cir.)[More...]
View ArticleThe America Invents Act: Basic Information for Patent Owners and Inventors
The United States passed a radically new patent statute, the Leahy-Smith America Invents Act ("AIA"), on September 16, 2011. The AIA has some provisions already in effect and others that will become...
View ArticleNovo Nordisk Requests FDA Advisory Opinion Concerning Orange Book Listing Of...
Novo Nordisk recently became the fourth company to ask FDA for guidance concerning whether patents on pre-filled drug delivery devices should be listed in the Orange Book. Novo markets several drug...
View Article"Defective" Complaint Triggers 30-Month Stay
In an opinion filed on Monday, the U.S. District Court for the District of Delaware granted leave to Endo Pharmaceuticals to file an amended complaint to correct a defective initial complaint. In...
View Article